CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism

Experimental Hematology

Volumn 27, Issue 9, 1999, Pages 1402-1408

  Daniel, Peter T ^a   Scholz, Christian ^a   Eßmann, Frank ^a   Westermann, Jörg ^a   Pezzutto, Antonio ^a   Dörken, Bernd ^a  

^a HELIOS Clinic Berlin Buch   (Germany)

Author keywords

Apoptosis inhibition; CD58; Dendritic cells

Indexed keywords

ANTIBODY; CASPASE; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

APOPTOSIS; ARTICLE; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD58; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME ACTIVATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MONOCYTES; T-LYMPHOCYTES;

EID: 0032845406     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00079-X     Document Type: Article

References (24)

1. Dhein J., Walczak H., Baumler C., Debatin K.M., Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:1995;438.
2. Lagresle C., Bella C., Daniel P.T., Krammer P.H., Defrance T. Regulation of germinal center B cell differentiation. Role of the human APO-. 1(Fas (CD95) molecule. J. Immunol 154):1995;5746.
3. Nagata S., Goldstein P. The Fas death factor. Science. 267:1995;1449.
4. Daniel P.T., Krammer P.H. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol. 152:1994;5624.
5. Daniel P.T., Oettinger U., Mapara M.Y., Bommert K., Bargou R., Dörken B. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells. lack of CD95 (Fas/Apo-1) ligand expression and function Eur J Immunol. 27:1997;1029.
6. Daniel P.T., Kroidl A., Cayeux S., Bargou R., Blankenstein T., Dörken B. Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis. J Immunol. 159:1997;3808.
7. Daniel P.T., Kroidl A., Kopp J., Sturm I., Moldenhauer G., Dörken B., Pezzutto A. Immunotherapy of B cell lymphoma with CD3x19 bispecific antibodies. costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic T cells Blood. 92:1998;4750.
8. Leithäuser F., Dhein J., Mechtersheimer G., Koretz K., Brüderlein S., Henne C., Schmidt A., Debatin K.M., Krammer P.H., Möller P. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor superfamily, in normal and neoplastic cells. Lab Invest. 69:1993;415.
9. Medvedev A., Johnsen A.C., Haux J., Steinkjer B., Egeberg K., Lynch D.H., Sundan A., Espevik T. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and involvement of Fas ligand in NK/LAK cell-mediated cytotoxicity. Cytokine. 9:1997;394.
10. Lu L., Quian S., Hershberger P.A., Rudert W.A., Lynch D.H., Thomson A.W. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol. 158:1997;5676.
11. O'Connell J., O'Sullivan G.C., Collins J.K., Shanahan F. The Fas counterattack. Fas-mediated killing by colon cancer cells expressing Fas ligand J Exp Med. 184:1996;1075.
12. Aicher A., Westermann J., Cayeux S., Willimsky G., Daemen K., Blankenstein T., Uckert W., Dörken B., Pezzutto A. Successful retroviral mediated transduction of a reporter gene in human dendritic cells. feasibility of therapy in gene-modified antigen presenting cells Exp Hematol. 25:1997;39.
13. Dhein J., Daniel P.T., Trauth B.C., Oehm A., Möller P., Krammer P.H. Induction of apoptosis by monoclonal antibody anti APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol. 149:1992;3166.
14. Klas C., Debatin K.M., Jonker R.R., Krammer P.H. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol. 5:1993;625.
15. Sanchez-Madrid F., Krensky A.M., Ware C.F., Robbins E., Strominger J.L., Burakoff S.J., Springer T.A. Three distinct antigens associated with T-lymphocyte mediated cytolysis. LFA-1, LFA-2, and LFA-3 Proc Natl Acad Sci U S A. 79:1982;7489.
16. Ohno H., Ushiyama C., Taniguchi M., Germain R.N., Saito T. CD2 can mediate TCR/CD3-independent T cell activation. J Immunol. 146:1991;3742.
17. Meuer S.C., Hussey R.E., Fabbi M., Fox D., Acuto O., Fitzgerald K.A., Hodgdon J.L., Potentis J.F., Schlossman S.F., Reinherz E.L. An alternative pathway of T-cell activation. a functional role for the 50 kD T11sheep erythrocyte receptor protein Cell. 36:1984;897.
18. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 14:1996;233.
19. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T., Thompson C.B. CD28 costimulation can promote survival by enhancing the expression of Bcl-xL. Immunity. 3:1995;87.
20. Siefken R., Kurrle R., Schwinzer R. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex. Cell Immunol. 176:1997;59.
21. Siefken R., Klein-Heßling S., Serfling E., Kurrle R., Schwinzer R. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without T cell receptor engagement. J Immunol. in press:1998.
22. Chu Z.-L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NFκB control. Proc Natl Acad Sci U S A. 94:1997;10057.
23. Scholz C., Freeman G.J., Greenfield E.A., Hafler D.A., Höllsberg P. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation. J Immunol. 157:1996;2932.
24. Scholz C., Patton K., Anderson D., Freeman G.J., Hafler D.A. Expansion of autoreactive myelin basic protein reactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol. 160:1998;1532.